글로벌 층상어류증 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 층상어류증 시장

층상어류증 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 상기 연구 예측 기간 동안 5.60%의 CAGR로 성장하고 있다고 분석합니다. 유아 발병률 증가와 우울증을 포함한 관련 증상의 증가.

기술적 발전과 의료 기기 에 대한 환불 가능성 도 시장 성장을 촉진합니다. 게다가 연구 개발 증가, 파이프라인 치료법의 존재, 의료비 지출 증가는 시장 성장의 기회로 작용합니다. 그러나 치료 옵션과 관련된 부작용과 엄격한 규제 프레임워크 등이 글로벌 층상어류증 시장을 방해할 수 있습니다.

층상어류증은 유전적 피부 질환입니다. 이는 선천적으로 사람에게 영향을 미치는 것으로 보고되었습니다. 층상어류증을 앓는 환자는 손바닥과 발바닥에 매우 두꺼운 피부가 생기고, 게다가 피부가 빨갛고 건조하며 거칠어집니다. 층상어류증은 산전 진단 방법, 피부 생검, 초음파 등을 통해 진단할 수 있습니다. 전신 치료, 안구 치료 , 국소 치료 및 수술은 층상어류증 치료에 사용됩니다. 층상어류증에 사용되는 전신 치료에는 에트레티네이트, 리아로졸, 이소트레티노인을 포함한 경구 레티노이드가 포함됩니다. 층상어류증 치료에 제안된 안구 치료에는 카르복시메틸셀룰로오스 나트륨, 바세린, 미네랄 오일 등이 있습니다. 살리실산, 레티노산 등을 함유한 연고는 층상어류증 치료를 위한 국소 치료로 사용됩니다. 층상성 어린이 피부증을 앓는 환자에게 나타나는 흉터성 외반은 인간의 피부에 대응하는 아플리그라프 시술을 통해 치료할 수 있습니다.

The infant population subjected to heredity diseases including lamellar ichthyoses is increasing worldwide. This patient population are largely dependent upon the advanced diagnostic and treatment options and hence expected to provide market with the lucrative growth. It is also estimated that lamellar ichthyosis market is growing with the CAGR of 5.60% in 2020.

This lamellar ichthyosis market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Lamellar Ichthyosis Market Scope and Market Size

Lamellar ichthyosis market is segmented on the basis of diagnosis, treatment, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of diagnosis, the lamellar ichthyosis market is segmented into prenatal diagnosis, immunohistochemistry, skin biopsy and others.
• On the basis of treatment, the lamellar ichthyosis market is segmented into petrolatum-based creams and ointments, artificial tears, retinoid, others.
• On the basis of route of administration, the lamellar ichthyosis market is segmented into oral, topical and others.
• On the basis of end-users, the lamellar ichthyosis market is segmented into clinics, hospitals, diagnostic centers and others.
• On the basis of distribution channel, the lamellar ichthyosis market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy, others.

Lamellar ichthyosis Market Country Level Analysis

Lamellar ichthyosis market is analysed and market size information is provided by country, treatment, product, site, end-users and distribution channel as referenced above.

The countries covered in the lamellar ichthyosis market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to the increasing prevalence of lamellar ichthyoses and increasing funding activities by U.S FDA for accelerating the research activities targeting rare diseases. Europe is also expected to the grow due to rising initiative by regulatory agencies and rising number of orphan drug designation to drug manufactured for rare disease treatment.

For instance,

• In August 2018, Krystal Biotech received orphan drug designation for its product candidate KB105 indicated for treatment of ichthyosis in paitent diagnosed with deficiency of transglutaminase 1 (TGM-1). This designation boosted the company’s research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Lamellar ichthyosis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Lamellar Ichthyosis Market Share Analysis

Lamellar ichthyosis market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to lamellar ichthyosis market.

층상성 어류증 시장의 주요 기업으로는 Timber Pharmaceuticals LLC, Patagonia Pharmaceuticals, LLC, Galderma, Mayne Pharma Group Limited, Krystal Biotech, LGM Pharma, ANAPTYSBIO, INC., F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries, Inc., Teva Pharmaceuticals USA, Inc., Biophore, Sonneborn LLC, Genentech, Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Illumina, Inc, Natera Inc., ELITech Group, ThermoFisher Scientific, Inc., Danaher, PerkinElmer, Inc., Abcam plc, Merck KGaA 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-61103